A Study of Silmitasertib (CX-4945) in Healthy Subject
NCT05817708
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
30
Enrollment
INDUSTRY
Sponsor class
Conditions
COVID-19
Interventions
DRUG:
CX-4945
Sponsor
Senhwa Biosciences, Inc.